GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
T

Toho Holdings Co 8129.T · JPY

Health Care · Tokyo Stock Exchange · 🇯🇵 Japan

Compare

3,923

+1.84%

Close of 9 Nov 2026, in JPY

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About Toho Holdings Co

Its shares trade on Tokyo Stock Exchange under the ticker 8129.T. It has been listed since 11 December 2002. In the fiscal year to 31 March 2026, it reported revenue of ¥1.55trn and net income of ¥17.33bn. At that date it held total assets of ¥740.78bn and shareholders' equity of ¥271.43bn.

Toho Holdings Co., Ltd. engages in the planning and management of its group of companies, which have interests in the pharmaceutical business. The company is headquartered in Setagaya, Tokyo-To. The company went IPO on 2002-12-11. The firm operates in four business segments. The Pharmaceutical Wholesale segment purchases pharmaceuticals and medical-related products from pharmaceutical manufacturers and distributes them to the hospitals, clinics and dispensing pharmacies. The Dispensing Pharmacy segment is engaged in the operation of dispensing pharmacies. The Clinical Trial Facilities Support segment is engaged in the provision of support services for clinical trial facilities. The Information Equipment Sale segment is engaged in the planning and sale of information processing equipment.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
Health Care
Industry
Health Care Providers & Services
Listed since
11 Dec 2002
Employees
7,937

Leadership

Pay as last reported

  • Mr. Hiromi EdahiroChief Executive Officer, Chief Financial Officer, Representative Director, since 2015
  • Mr. Takeo MatsutaniChairman of Subsidiary, Director, since 2003
  • Mr. Akira UmadaSenior Managing Director, Chief Operating Officer, President of Subsidiary, since 2016
  • Mr. Satoshi IkedaExecutive Officer
  • Mr. Makoto KawamuraExecutive Officer
  • Ms. Aya KomaiExecutive Officer, Director of Pharmajoy Tokyo, Assistant Manager of Pharmaceutical Affairs Supervision Unit
  • Mr. Shuzo KonoExecutive Officer
  • Mr. Tsuguo NakagomiExecutive Officer, since 2017
  • Mr. Shigeki NakataExecutive Officer
  • Ms. Aiko NoshiroExecutive Officer, Director of Public Relations in Main Public Relations and International Relations
  • Mr. Kengo OgawaExecutive Officer, since 2013
  • Mr. Kazuki ShimizuExecutive Officer, Manager of Secretary Office, since 2023

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
70
Environment
52
Social
84
Governance
75
Direct emissions (scope 1)
13,915 t
Energy emissions (scope 2)
16,001 t
Value chain emissions (scope 3)
2,105,528 t
Women in the workforce
47.6%
Carbon reduction policy
Yes
Human rights policy
Yes

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • Toho Holdings Co Ltd possesses several strengths that contribute to its competitive advantage and success in the market. These strengths include:

Weaknesses

  • Toho Holdings Co Ltd also has some weaknesses that need to be addressed in order to maintain its competitiveness:

Opportunities

  • Toho Holdings Co Ltd can explore various opportunities to further expand its business and improve its market position:

Threats

  • Toho Holdings Co Ltd faces several threats in its operational environment that could impact its business negatively:

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.